MRPS11
geneOn this page
Also known as FLJ23406HCC-2FLJ22512uS11m
Summary
MRPS11 (mitochondrial ribosomal protein S11, HGNC:14050) is a protein-coding gene on chromosome 15q25.3, encoding Small ribosomal subunit protein uS11m (P82912). It is a selective cancer dependency (DepMap: 73.8% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that contains a high level of sequence similarity with ribosomal protein S11P family members. A pseudogene corresponding to this gene is found on chromosome 20. Multiple transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 64963 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 39 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 73.8% of screened cell lines
- MANE Select transcript:
NM_022839
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14050 |
| Approved symbol | MRPS11 |
| Name | mitochondrial ribosomal protein S11 |
| Location | 15q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23406, HCC-2, FLJ22512, uS11m |
| Ensembl gene | ENSG00000181991 |
| Ensembl biotype | protein_coding |
| OMIM | 611977 |
| Entrez | 64963 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 10 protein_coding, 7 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000325844, ENST00000353598, ENST00000557974, ENST00000558406, ENST00000558548, ENST00000559125, ENST00000559323, ENST00000559557, ENST00000560708, ENST00000560850, ENST00000561262, ENST00000892746, ENST00000892747, ENST00000915412, ENST00000915413, ENST00000915414, ENST00000915415, ENST00000958955, ENST00000958956
RefSeq mRNA: 6 — MANE Select: NM_022839
NM_001321970, NM_001321972, NM_001321973, NM_001321974, NM_022839, NM_176805
CCDS: CCDS10342, CCDS10343
Canonical transcript exons
ENST00000325844 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001268054 | 88477872 | 88480776 |
| ENSE00003521205 | 88475110 | 88475239 |
| ENSE00003528897 | 88472627 | 88472725 |
| ENSE00003561493 | 88467908 | 88468024 |
| ENSE00003612177 | 88476989 | 88477054 |
| ENSE00003844252 | 88467708 | 88467782 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 96.71.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 89.2926 / max 638.9121, expressed in 1827 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 148277 | 77.4327 | 1825 |
| 148276 | 11.8410 | 1801 |
| 148278 | 0.0189 | 6 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 96.71 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.66 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.98 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.91 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.88 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.78 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.73 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.72 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.52 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.37 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.19 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.04 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.96 | gold quality |
| adrenal gland | UBERON:0002369 | 93.88 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.79 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.75 | gold quality |
| muscle of leg | UBERON:0001383 | 93.75 | gold quality |
| heart | UBERON:0000948 | 93.41 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.30 | gold quality |
| prefrontal cortex | UBERON:0000451 | 93.15 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.10 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.73 | gold quality |
| thyroid gland | UBERON:0002046 | 92.67 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.56 | gold quality |
| stromal cell of endometrium | CL:0002255 | 92.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.36 | gold quality |
| transverse colon | UBERON:0001157 | 92.32 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.16 | gold quality |
| esophagus mucosa | UBERON:0002469 | 92.15 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.11 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.24 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
67 targeting MRPS11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-1287-3P | 99.63 | 66.93 | 492 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 73.8% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- The downregulated gene with the largest effect size in ankylosing spondylitis was mitochondrial ribosomal protein S11 (MRPS11). (Meta-analysis) (PMID:26125709)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps11 | ENSDARG00000075129 |
| mus_musculus | Mrps11 | ENSMUSG00000030611 |
| rattus_norvegicus | Mrps11 | ENSRNOG00000018531 |
| rattus_norvegicus | ENSRNOG00000085276 | |
| drosophila_melanogaster | mRpS11 | FBGN0038474 |
| caenorhabditis_elegans | WBGENE00012244 |
Paralogs (1): RPS14 (ENSG00000164587)
Protein
Protein identifiers
Small ribosomal subunit protein uS11m — P82912 (reviewed: P82912)
Alternative names: 28S ribosomal protein S11, mitochondrial, Cervical cancer proto-oncogene 2 protein
All UniProt accessions (2): P82912, H0YL99
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the universal ribosomal protein uS11 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P82912-1 | 1 | yes |
| P82912-2 | 2 | |
| P82912-3 | 3 |
RefSeq proteins (4): NP_001308899, NP_001308901, NP_073750, NP_789775 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001971 | Ribosomal_uS11 | Family |
| IPR018102 | Ribosomal_uS11_CS | Conserved_site |
| IPR036967 | Ribosomal_uS11_sf | Homologous_superfamily |
Pfam: PF00411
UniProt features (20 total): strand 7, helix 4, turn 2, splice variant 2, sequence variant 2, transit peptide 1, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
75 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
| 9HFM | ELECTRON MICROSCOPY | 3 |
| 9H54 | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P82912-F1 | 82.69 | 0.66 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 135 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_MITOCHONDRIAL_TRANSLATION, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_TRANSLATION, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, MORF_PPP6C, GOCC_MITOCHONDRIAL_ENVELOPE, GARY_CD5_TARGETS_DN, DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER, GOCC_RIBOSOME, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
4847 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS11 | MRPL21 | Q7Z2W9 | 652 |
| MRPS11 | MRPL13 | Q9BYD1 | 640 |
| MRPS11 | MRPS16 | Q9Y3D3 | 618 |
| MRPS11 | MRPS12 | O15235 | 617 |
| MRPS11 | MRPS14 | O60783 | 617 |
| MRPS11 | MRPS2 | Q9Y399 | 588 |
| MRPS11 | MRPS9 | P82933 | 578 |
| MRPS11 | MRPL16 | Q9NX20 | 575 |
| MRPS11 | MRPL11 | Q9Y3B7 | 574 |
| MRPS11 | MRPS35 | P82673 | 572 |
| MRPS11 | MRPL36 | Q9P0J6 | 572 |
| MRPS11 | MTRF1 | O75570 | 569 |
| MRPS11 | MRPS10 | P82664 | 563 |
| MRPS11 | MRPS7 | Q9Y2R9 | 561 |
| MRPS11 | MRPS15 | P82914 | 559 |
IntAct
123 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| NAA10 | MRPS11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.550 |
| MRPS18B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF169 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF331 | USP9Y | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| ZBTB48 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| E4F1 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| ZFC3H1 | HNRNPCL1 | psi-mi:“MI:0914”(association) | 0.530 |
| IGF2BP3 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS15 | PRKACG | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS11 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| WDTC1 | TCP1 | psi-mi:“MI:0914”(association) | 0.530 |
| LIN28B | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL19 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| HNRNPU | MRPS11 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF460 | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS14 | CBX6 | psi-mi:“MI:0914”(association) | 0.530 |
| PRR3 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| AURKAIP1 | NRDC | psi-mi:“MI:0914”(association) | 0.480 |
| MRPS11 | SRPK2 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
BioGRID (320): MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS11 (Affinity Capture-MS), MRPS9 (Affinity Capture-MS), CUL4A (Affinity Capture-MS), PTCD3 (Affinity Capture-MS), MTIF2 (Affinity Capture-MS), DCAF5 (Affinity Capture-MS)
ESM2 similar proteins: A0Q4K5, A4G9R6, A4IZR2, A5ELK5, A6T3I1, A7N9U6, B0U0W8, B0U5M0, B2I8J0, B2SDW3, B3QBV7, O22795, P22798, P25873, P30956, P31164, P31165, P42732, P59755, P82163, P82191, P82195, P82245, P82278, P82413, P82912, Q07KP0, Q0BNQ6, Q0BYD6, Q134V1, Q14J98, Q1H4L4, Q1QN08, Q211H0, Q2A5E8, Q2IXN8, Q3SLM7, Q4FLN9, Q5NHU6, Q6N4V5
Diamond homologs: A0T0Z3, A1KB03, A2BTB6, A2CC50, A2SLD3, A3DA49, A3M961, A3PF26, A4J137, A4XLQ4, A5CXI7, A5EX96, A5FRX0, A5GIS3, A5GVY2, A5IV09, A5USG4, A6MW21, A6QJ67, A6U3V0, A6WHV1, A7HBP3, A7X5C5, A8YXM9, A8Z332, B0C431, B0JY39, B0K5R9, B0KCM6, B0V6U5, B0VQU1, B1I1B1, B2HZ85, B2SDW2, B3PK60, B4RT51, B5XJ61, B7GW25, B7IA16, B7K225
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS11 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 139 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 16 | 23.4× | 6e-16 |
| Mitochondrial translation initiation | 17 | 22.9× | 2e-16 |
| Mitochondrial translation elongation | 17 | 22.9× | 2e-16 |
| Mitochondrial ribosome-associated quality control | 17 | 22.2× | 2e-16 |
| Mitochondrial translation termination | 17 | 19.9× | 8e-16 |
| Translation | 21 | 13.9× | 2e-16 |
| Influenza Viral RNA Transcription and Replication | 5 | 11.5× | 5e-03 |
| rRNA processing | 6 | 9.3× | 4e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 19 | 26.6× | 2e-19 |
| translation | 15 | 12.4× | 4e-10 |
| regulation of alternative mRNA splicing, via spliceosome | 6 | 11.8× | 2e-03 |
| ribosomal small subunit biogenesis | 6 | 11.0× | 2e-03 |
| RNA processing | 6 | 10.6× | 2e-03 |
| cytoplasmic translation | 6 | 9.0× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
39 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 393972 | GRCh37/hg19 15q25.3-26.1(chr15:88295992-94215607)x1 | Pathogenic |
SpliceAI
1055 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:88467778:GCCGG:G | donor_gain | 1.0000 |
| 15:88467824:GAC:G | donor_gain | 1.0000 |
| 15:88468022:CAGGT:C | donor_loss | 1.0000 |
| 15:88468023:AGGTG:A | donor_loss | 1.0000 |
| 15:88468025:GTG:G | donor_loss | 1.0000 |
| 15:88468026:T:G | donor_loss | 1.0000 |
| 15:88475164:T:TA | acceptor_gain | 1.0000 |
| 15:88476988:GA:G | acceptor_gain | 1.0000 |
| 15:88476988:GAGA:G | acceptor_gain | 1.0000 |
| 15:88477870:A:AG | acceptor_gain | 1.0000 |
| 15:88477871:G:GG | acceptor_gain | 1.0000 |
| 15:88477871:GTCT:G | acceptor_gain | 1.0000 |
| 15:88467723:GGCT:G | donor_gain | 0.9900 |
| 15:88467724:GCTG:G | donor_gain | 0.9900 |
| 15:88467781:GG:G | donor_gain | 0.9900 |
| 15:88467782:GG:G | donor_gain | 0.9900 |
| 15:88472726:G:GG | donor_gain | 0.9900 |
| 15:88475162:T:TA | acceptor_gain | 0.9900 |
| 15:88476986:CAGAG:C | acceptor_gain | 0.9900 |
| 15:88476987:A:AG | acceptor_gain | 0.9900 |
| 15:88476987:AGAGA:A | acceptor_gain | 0.9900 |
| 15:88476988:G:GG | acceptor_gain | 0.9900 |
| 15:88476988:GAGAG:G | acceptor_gain | 0.9900 |
| 15:88477871:GT:G | acceptor_gain | 0.9900 |
| 15:88477871:GTC:G | acceptor_gain | 0.9900 |
| 15:88468025:G:GG | donor_gain | 0.9800 |
| 15:88472498:G:GT | donor_gain | 0.9800 |
| 15:88472499:A:T | donor_gain | 0.9800 |
| 15:88475165:G:A | acceptor_gain | 0.9800 |
| 15:88475236:GGCG:G | donor_gain | 0.9800 |
AlphaMissense
1247 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:88475177:T:C | F117L | 0.993 |
| 15:88475179:T:A | F117L | 0.993 |
| 15:88475179:T:G | F117L | 0.993 |
| 15:88477914:T:C | S174P | 0.980 |
| 15:88472701:C:A | A86E | 0.978 |
| 15:88475223:G:A | G132D | 0.978 |
| 15:88477023:T:A | V149D | 0.978 |
| 15:88475178:T:C | F117S | 0.977 |
| 15:88475234:G:C | A136P | 0.976 |
| 15:88472682:T:C | F80L | 0.975 |
| 15:88472684:T:A | F80L | 0.975 |
| 15:88472684:T:G | F80L | 0.975 |
| 15:88475164:T:G | C112W | 0.973 |
| 15:88477020:G:C | R148P | 0.971 |
| 15:88476992:G:C | A139P | 0.967 |
| 15:88475219:G:C | A131P | 0.964 |
| 15:88475163:G:A | C112Y | 0.963 |
| 15:88475235:C:A | A136E | 0.961 |
| 15:88476993:C:A | A139D | 0.961 |
| 15:88472707:T:A | I88N | 0.960 |
| 15:88477876:C:A | A161D | 0.960 |
| 15:88475208:C:A | A127E | 0.959 |
| 15:88477049:C:A | R158S | 0.958 |
| 15:88475118:T:C | I97T | 0.957 |
| 15:88475194:G:C | K122N | 0.957 |
| 15:88475194:G:T | K122N | 0.957 |
| 15:88477034:G:C | G153R | 0.956 |
| 15:88475231:G:C | A135P | 0.955 |
| 15:88477050:G:C | R158P | 0.954 |
| 15:88477923:G:C | D177H | 0.954 |
dbSNP variants (sampled 300 via entrez): RS1000088800 (15:88466395 T>G), RS1000183225 (15:88466131 A>C), RS1000251085 (15:88471184 A>G), RS1000348441 (15:88470266 G>T), RS1000397513 (15:88476705 G>A,T), RS1000574538 (15:88477181 C>T), RS1000631076 (15:88475681 A>T), RS1000681546 (15:88471641 A>C,G), RS1000789126 (15:88470945 C>A), RS1000852445 (15:88470564 A>C), RS1000984358 (15:88477460 G>A), RS1001278893 (15:88474704 T>C), RS1001440725 (15:88469415 C>T), RS1001708323 (15:88471630 TA>T), RS1001747901 (15:88469016 A>G)
Disease associations
OMIM: gene MIM:611977 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004736_4 | Familial hepatitis B virus-related hepatocellular carcinoma | 7.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | increases expression, decreases expression | 3 |
| bisphenol A | affects cotreatment, increases methylation, decreases expression | 2 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | increases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | decreases expression, affects cotreatment | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| corosolic acid | decreases expression | 1 |
| ICG 001 | decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Cisplatin | increases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lead | affects splicing | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Metribolone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hepatocellular carcinoma